Axitinib for treating advanced renal cell carcinoma after failure of prior systemic treatment. NICE technology appraisal guidance 333
National Institute for Health and Care Excellence (NICE)
Record ID 32018011446
English
Details
Project Status:
Completed
URL for project:
https://www.nice.org.uk/guidance/ta333
Year Published:
2015
URL for published report:
https://www.nice.org.uk/guidance/ta333
English language abstract:
An English language summary is available
Publication Type:
Full HTA
Country:
England
MeSH Terms
- Carcinoma, Renal Cell
- Kidney Neoplasms
- Axitinib
- Antineoplastic Agents
- Protein Kinase Inhibitors
Contact
Organisation Name:
National Institute for Health and Care Excellence
Contact Address:
Level 1A, City Tower, Piccadilly Plaza, Manchester, M1 4BT
Contact Name:
nice@nice.nhs.uk
Contact Email:
nice@nice.nhs.uk
Copyright:
National Institute for Health and Care Excellence (NICE)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.